Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and <i>Streptococcus pneumoniae</i>-Reference-Cited by-同舟云学术

Rational Development of a Polysaccharide–Protein‐Conjugated Nanoparticle Vaccine Against SARS‐CoV‐2 Variants and Streptococcus pneumoniae

Published:2022-04-21 Issue:21 Volume:34 Page:2200443
ISSN:0935-9648
Container-title:Advanced Materials
language:en
Short-container-title:Advanced Materials

Author:

Deng Yongqiang¹,Li Jing²,Sun Chunyun²,Chi Hang¹,Luo Dan¹,Wang Rui²,Qiu Hongying¹,Zhang Yanjing²,Wu Mei¹,Zhang Xiao²,Huang Xun¹,Xie Liangzhi²,Qin Chengfeng¹³^ORCID

Affiliation:

1. Department of Virology State Key Laboratory of Pathogen and Biosecurity Beijing Institute of Microbiology and Epidemiology AMMS Beijing 100071 P. R. China

2. Beijing Protein and Antibody R&D Engineering Center Sinocelltech Ltd. Beijing 100176 P. R. China

3. Research Unit of Discovery and Tracing of Natural Focus Diseases Chinese Academy of Medical Sciences Beijing 100071 P. R. China

Funder

National Natural Science Foundation of China

National Science Fund for Distinguished Young Scholars

Publisher

Wiley

Subject

Mechanical Engineering,Mechanics of Materials,General Materials Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adma.202200443

Reference55 articles.